Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Sean Parker Gives $24 Million to Stanford to Study Food Allergies

Parker suffers from severe food allergies, and now he’s hoping to help fund a cure.

B Calkins/Shutterstock

Silicon Valley investor Sean Parker will donate $24 million to fund Stanford University School of Medicine researchers looking for new ways to treat severe food allergies in children and adults with the goal of developing a cure.

Parker has spoken about his severe food allergies before, most notably a scary incident three years ago in Davos during the World Economic Forum when he was rushed to the hospital.

It was one of about 14 trips to the emergency room that Parker estimated he has taken in the past four or so years.

Parker says he’s allergic to peanuts, tree nuts such as pecans, shellfish and a few legumes. He has suffered from severe food allergies since he was a child.

“I understand firsthand how difficult it is to handle this,” Parker told reporters earlier this week. The school has established the Sean N. Parker Center for Allergy Research, which the Facebook investor will fund over the next two years.

He said one reason he decided to fund the new center is that he is now a father and understands the fear his parents went through when he was a child. Parker’s wife, Alexandra, gave birth to the couple’s second child, a boy, a few weeks ago. It’s too early to know if he might also have food allergies. But the couple’s older child, a two-year-old daughter, so far has had no food-related allergic reactions, Parker said.

Allergy research has taken a backseat to other forms of immunological diseases, Parker said, which is partly why he was interested in funding the new Stanford research center, which will focus on finding better treatments for allergies as well as looking at why people develop them.

“There are huge gaps in our knowledge,” said Dr. Kari Nadeau, an immunology researcher who will lead the new research center. Parker says Facebook Chief Operating Officer Sheryl Sandberg introduced him to Nadeau, who has gained some fame in the food allergy world for her research at Stanford involving a desensitizing plan for patients who suffer from allergies to multiple foods. Her work was featured in a New York Times magazine story last year.

This article originally appeared on Recode.net.

See More:

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh